¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Death studies."¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
¿µ¹® brain death ÇÑ±Û ³ú»ç
¼³¸í   
  ³ú±â´ÉÀÌ ¿ÏÀüÈ÷ Á¤ÁöµÇ¾î È¸º¹ ºÒ´ÉÇÑ »óÅÂ. ³úÀÇ ±â´É¿¡´Â ´ë³ú¹Ý±¸ÀÇ ±â´É À̿ܿ¡ ³ú°£ÀÇ ±â´Éµµ Æ÷ÇԵȴÙ. ³ú»ç´Â Àΰ£ÀÇ Á×À½°ú °°Àº ¶æÀÌ ¾Æ´Ï°í, º¸ÅëÀº ³ú»ç ´ÙÀ½¿¡ Á×À½ÀÌ ¿Â´Ù. ½ÉÀåÀ̽Ġ¼ö¼ú¿¡´Â °¡´ÉÇÑ ÇÑ ½Å¼±ÇÑ ½ÉÀåÀÌ ÇÊ¿äÇϱ⠶§¹®¿¡ ½ÉÀå Á¦°øÀÚÀÇ Á×À½À» ³ú»ç·Î ±ÔÁ¤ÇÏ·Á´Â ¿òÁ÷ÀÓÀÌ ÀÖ¾ú´Ù. 1968³â 8¿ù ¼¼°èÀÇ»çȸ ÃÑȸ¿¡¼­ Ã¤ÅõȠÀå±âÀ̽Ŀ¡ °üÇÑ ¼±¾ð(½Ãµå´Ï ¼±¾ð)¿¡¼­´Â ¨ç ½ÉÀå Á¦°øÀÚÀÇ Á×À½ÀÇ ÆÇÁ¤Àº ³úÆÄÃøÁ¤»óÀÇ ³úÆÄÀÇ Á¤Áö(³ú»ç)·Î °áÁ¤ÇؾߠÇÑ´Ù. ¨è Á¦°øÀÚÀÇ Á×À½À» È®ÀÎÇϴµ¥ µÎ¸íÀÌ»óÀÇ Àǻ簡 ÀÔÈ¸ÇØ¾ß Çϸç, ³ú»çÀÇ °áÁ¤¿¡ Âü¿©ÇÑ ÀÇ»ç´Â À̽ļö¼ú¿¡ °ü¿©Çؼ­´Â ¾È µÈ´Ù°í Çß´Ù. ±×·¯³ª ³úÆÄÃøÁ¤¸¸À¸·Î´Â ³úÁÙ±âÀÇ ±â´ÉÁ¤Áö¸¦ ÆÇÁ¤ÇÒ ¼ö ¾ø°í, ³ú»çÀÇ ÆÇÁ¤µµ Áúº´ÀÇ Á¾·ù³ª Áøµµ¿¡ µû¶ó ±âÁØÀÌ ´Þ¶óÁö¹Ç·Î ÆÇÁ¤±âÁØÀÇ °ËÅä°¡ ÇÊ¿äÇÏ´Ù. ³úÁ¾¾ç-³ú¿Ü»ó-Ç÷ÇàÀå¾Ö µî ³úÁúȯÀÇ Áõ·Ê¿¡¼­ º¸¸é ¨ç ±íÀº È¥¼ö, ¨è ¾çÂÊ µ¿°øÀÇ È®´ë ¹× µ¿°øÀÇ ºû¹Ý»ç¿Í °¢¸·¹Ý»çÀÇ ¼Ò½Ç, ¨é È£ÈíÀÇ Á¤Áö, ¨ê ³úÆÄÀÇ Æòźȭ, ¨ë Ç÷¾ÐÀÇ ±Þ°ÝÇÑ ÀúÇϿ͠±×¿¡ µû¸¥ ÀúÇ÷¾Ð µî ´Ù¼¸ °¡Áö Á¶°ÇÀÌ 6½Ã°£ ÈÄ¿¡µµ µ¿ÀÏÇÑ »óÅ¿¡ Àִ °Í µî ¿©¼¸°¡Áö Á¶°ÇÀÌ ÆÇÁ¤ ±âÁØÀÌ µÇ¾ú¾ú´Ù. ÇöÀç´Â °¡Àå °­·ÂÇÑ µ¿ÅëÀڱؿ¡ ´ëÇØ¼­µµ ÀüÇô ¾Æ¹«·± °¨¼ö¼º°ú ¹ÝÀÀ¼ºÀ» ³ªÅ¸³»Áö ¾Ê´Â 24½Ã°£¿¡ °ÉÄ£ È¥¼ö·Î¼­, Àڹ߿ ¶Ç´Â ÀÚ¹ßÈ£ÈíÀÌ ¾ø°í À¯¹ß¹Ý»ç°¡ ¼Ò½ÇµÇ°í ³úÀÇ Àü±âȰµ¿ÀÌ ¾ø¾îÁö´Â È¸º¹ºÒ°¡´ÉÇÑ ÀǽļҽÇÀ̶ó°í Á¤ÀÇÇϰí ÀÖ´Ù.
¿µ¹® death ÇÑ±Û »ç¸Á, Á×À½, »ç
¼³¸í   
  1. »ý¸íȰµ¿ÀÌ Á¤ÁöµÇ¾î ´Ù½Ã ¿ø»óÅ·Πµ¹¾Æ¿ÀÁö ¾Ê´Â »ý¹°ÀÇ »óÅÂ. »îÀÇ Á¾¸»À» ¸»ÇÑ´Ù. ¿¹¸¦ µé¾î ¾Æ¸Þ¹Ù µîÀÇ ´Ü¼¼Æ÷ »ý¹°¿¡¼­´Â 2°³Ã¼·Î ºÐ¿­µÉ ¶§°¡ Á×À½À̶ó°í ¸»ÇÒ ¼ö ÀÖÀ»Áö ¸ð¸£³ª ´Ù¼¼Æ÷ »ý¹°¿¡ À־´Â ¼¼Æ÷ºÐ¿­Àº ´Ü¼øÇÑ ¼ºÀåÀÇ ÇÑ °úÁ¤ÀÌ´Ù. »ý¹°Àº »ý½Ä¼¼Æ÷¸¦ ¸Å°³·Î »ý¸íÀ» ¿µ¿øÈ÷ Á¸¼Ó½Ã۴ °ÍÀ̶ó°í º¼ ¼ö ÀÖ´Ù. Àΰ£À» Æ÷ÇÔÇÑ °íµîµ¿¹°¿¡ ÇÑÁ¤ÇÑ´Ù°í Çϸé Á×À½À̶õ ±× °³Ã¼¸¦ ±¸¼ºÇϴ ¸ðµç Á¶Á÷ ¼¼Æ÷ÀÇ »ýȰ±â´ÉÀÇ Á¤Áö¶ó°í ¸»ÇÒ ¼ö ÀÖ´Ù. µû¶ó¼­, ±¹ºÎÀûÀΠÇÑ ºÎºÐÀÇ »ýȰ±â´ÉÀÇ Á¤Áö¸¸À¸·Î´Â Á×À½À̶ó°í ÇÒ ¼ö ¾ø´Ù. 2. »ç¶÷ÀÌ Á×À½. »ç¶÷ÀÇ Á×À½Àº ³× °³ÀÇ Ãø¸éÀÌ ÀÖ´Ù. Áï ¨ç À°Ã¼Àû Á×À½(biological death), ¨è ½É¸®Àû Á×À½(psychological death), ¨é »çȸÀû Á×À½(social death), ¨ê ¹®È­Àû Á×À½(culture death)À¸·Î »ý°¢ÇÒ ¼ö ÀÖ´Ù. Àΰ£ÀÇ ÀÏ»ýÀº ´ÜÁö »ý¸íÀÇ ¿¬Àå »Ó ¾Æ´Ï¶ó ÁúÀû Ãø¸é¿¡¼­ ½É¸®Àû, »çȸÀû, ¹®È­ÀûÀÎ Ãæ½ÇÇÔÀÌ ÇÊ¿äÇÏ´Ù. ±Ù³â¿¡ ÀÇ·á±â¼úÀÇ ´«ºÎ½Å ¹ß´Þ¿¡ µû¶ó¼­ ´õ¿í »ýȰÀÇ ÁúÀÌ Áß¿ä½ÃµÇ°í ÀÖ´Ù. ÀϹÝÀûÀ¸·Î À°Ã¼ÀûÀΠÁ×À½ÀÇ Á¤ÀǴ ¸ðµç »ýü±â´ÉÀÇ ¿µ±¸Àû Á¤Áö. Áï ¨ç Àüü³ú±â´É, ¨è È£Èí°èÀÇ Àڹ߱â´É, ¨é ¼øÈ¯°èÀÇ Àڹ߱â´É, ÀÌ ¸ðµç °ÍÀÇ ºñ°¡¿ªÀûÀ¸·Î Á¤ÁöµÇ¾úÀ½À» ¸»ÇÑ´Ù.
¿µ¹® sudden infant death syndrome ÇÑ±Û ¿µ¾Æ±Þ»çÁõÈıº
¼³¸í   
  ÇÑ »ì ÀÌÇÏÀÇ °Ç°­ÇÑ ¾Æ±â°¡ ¾Æ¹«·± Á¶ÁüÀ̳ª ¿øÀΠ¾øÀÌ °©Àڱ⠻ç¸ÁÇßÀ» °æ¿ì¿¡ ³»¸®´Â Áø´ÜÀÌ´Ù. ÀÌ ÁõÈıºÀº »ýÈÄ 1~4°³¿ù »çÀÌ¿¡ °¡Àå ¸¹ÀÌ ¹ß»ýÇϸç, ´ëºÎºÐ ¹ã 10½Ã¿¡¼­ ¿ÀÀü 10½Ã »çÀÌ¿¡ ¹ß»ýÇÑ´Ù. Á¶»êÇϰųª ºÎ¸ð°¡ Èí¿¬ÀÚÀÏ °æ¿ì, 20¼¼ ÀÌÇÏ »ê¸ðÀÇ ÃÊ»ê, ÀÓ½ÅÀü °Ç°­°ü¸®¿¡ ¼ÒȦÇÑ »ê¸ð¿¡°Ô¼­ Å¾ ¿µ¾Æ¿¡°Ô¼­ ¸¹ÀÌ ¹ß»ýÇÑ´Ù. ÀÌ ÁõÈıºÀ¸·Î »ç¸ÁÇÑ ¿µ¾ÆÀÇ ÇüÁ¦ÀÏ °æ¿ì ÀϹÝÀûÀΠ¿µ¾Æº¸´Ù °É¸± È®·üÀÌ ³ôÀº °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • accidental death
    »ç°í»ç, ÀçÇØ»ç
  • apparent death
    °¡»ç, °Ñº¸±â»ç¸Á
  • actual death rate
    ½ÇÁ¦»ç¸Á·ü
  • adjusted death rate
    Á¶Á¤»ç¸Á·ü
  • age-specific death rate
    ¿¬·Éº°»ç¸Á·ü
  • birth-death ratio
    Ãâ»ý»ç¸Áºñ
  • brain death
    ³ú»ç
  • brain death syndrome
    ³ú»çÁõÈıº
  • coronary death
    °ü»óµ¿¸Æ»ç, ½ÉÀ嵿¸Æ»ç
  • cardiac death
    ½ÉÀå»ç
  • corrected death rate
    Á¤Á¤»ç¸Á·ü
  • crib death
    ¿ä¶÷»ç
  • crude death rate
    º¸Åë»ç¸Á·ü, Á¶»ç¸Á·ü
  • cumulative death rate
    ´©Àû»ç¸Á·ü
  • cause of death
    »çÀÎ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • death
    »ç¸Á, Á×À½, »ç
  • accidental death
    »ç°í»ç, ÀçÇØ»ç
  • apparent death
    °¡»ç
  • brain death
    ³ú»ç
  • neonatal death
    ½Å»ý¾Æ»ç¸Á
  • sudden cardiac death
    ±Þ¼º½ÉÀå»ç
  • underlying cause of death
    ¼±Çà»ç¸Á¿øÀÎ
  • actual death rate
    ½ÇÁ¦»ç¸Á·ü
  • adjusted death rate
    (¢¡standardized death rate) Ç¥ÁØÈ­»ç¸Á·ü
  • crude death rate
    ÀϹݻç¸Á·ü, Á¶»ç¸Á·ü
  • fetal death rate
    žƻç¸Á·ü
  • standardized death rate
    Ç¥ÁØÈ­»ç¸Á·ü
  • sudden infant death syndrome
    ¿µ¾Æ±Þ»çÁõÈıº
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • accidental death
    »ç°í»ç, ÀçÇØ»ç
  • actual death rate
    ½ÇÁ¦»ç¸Á·ü
  • adjusted death rate
    (¢¡standardized death rate) Ç¥ÁØÈ­»ç¸Á·ü
  • age-specific death rate
    ¿¬·Éº°Æ¯¼ö»ç¸Á·ü
  • apparent death
    °¡»ç
  • death registration area
    »ç¸Áµî·ÏÁö¿ª
  • birth-death ratio
    Ãâ»ý»ç¸Áºñ
  • brain death
    ³ú»ç
  • brain death syndrome
    ³ú»çÁõÈıº
  • cause of death
    »ç¸Á¿øÀÎ
  • cardiac death
    ½ÉÀå»ç
  • cell death
    ¼¼Æ÷»ç
  • cerebral death
    (¢¡brain death) ³ú»ç
  • child death rate
    À¯¾Æ»ç¸Á·ü
  • coronary death
    ½ÉÀ嵿¸Æ»ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • gastric acid secretory studies
    À§»êºÐºñ °Ë»ç.
  • real-time studies
    ½Ç½Ã°£ °Ë»ç (ãùãÁÊà ËþÞÛ)
  • Death and dying
    »ç¸Á°úÀÓÁ¾
  • accelerated death phase
    °¡¼Ó»ç¸ê±â(˧ËÛË×ËÎË»).
  • accidental death
    »ç°í»ç, ÀçÇØ»ç .
  • accidental death
    »ç°í»ç(ÞÀͺÞÝ)
  • actual death rate
    ½ÇÁ¦»ç¸Á·ü(ËàÌ¡Ë×ËÎËô).
  • adjusted death rate
    Á¶Á¤»ç¸Á·ü.
  • age specific death rate
    ¿¬·Éº° »ç¸Á·ü
  • allergic death
    °ú¹Î»ç(ΦÚÂÞÝ).
  • apparent death
    °¡»ç(Ê£ÞÝ).
  • genetic death
    À¯Àü»ç(¡­ÞÝ).
  • heart death
    ½ÉÀå»ç(ãýíôÞÝ).
  • hebdomadal death rate
    »ýÈÄÀÏÁÖ°£»ç¸Á·ü(ÊÙË×ËÎËô).
  • infant death statistics
    ¿µ¾Æ»ç¸ÁÅë°è(ÊþËâË×ËÎ̬˭).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • gastric acid secretory studies
    À§»êºÐºñ °Ë»ç.
  • real-time studies
    ½Ç½Ã°£ °Ë»ç (ãùãÁÊà ËþÞÛ)
  • accelerated death phase
    °¡¼Ó»ç¸ê±â(˧ËÛË×ËÎË»).
  • accidental death
    »ç°í»ç(ÞÀͺÞÝ)
  • accidental death
    »ç°í»ç, ÀçÇØ»ç .
  • actual death rate
    ½ÇÁ¦»ç¸Á·ü(ËàÌ¡Ë×ËÎËô).
  • adjusted death rate
    Á¶Á¤»ç¸Á·ü.
  • age specific death rate
    ¿¬·Éº° »ç¸Á·ü
  • allergic death
    °ú¹Î»ç(ΦÚÂÞÝ).
  • apparent death
    °¡»ç(Ê£ÞÝ).
  • birth-death ratio
    Ãâ»ý-»ç¸Áºñ(õóßæÞÝØÌÝï).
  • birth-death ratio
    Ãâ»ý-»ç¸Áºñ(̧Ë×Ë×ËÎËÓ).
  • black death
    Èæ»çº´(Ì·Ë×ËÓ).
  • black death
    Èæ»çº´(ýÙÞÝÜ»).
  • bone marrow death
    °ñ¼ö»ç(ÍéâÐÞÝ).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Prenatal death
    Ãâ»ýÀü»ç¸Á
    [¿¾ ¿ë¾î] Ãâ»ýÀü»ç¸Á
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • death phase
    »ç¸ê±â(ÞÝØþÑ¢)
  • reproductive death
    Àç»ý ºÒ´É»ç(î¢ßæÝÕÒöÞÝ)
  • thermal death point
    ¿­»çÁ¡(æðÞÝïÃ)
  • thermal death time
    ¿­»ç½Ã°£ (æðÞÝãÁÊà)
  • thymineless death
    ŸÀ̹ΰῩ»ç (ÌÀåýÞÝ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • death
    Á×À½, »ç¸Á
  • fetal death
    žƻç¸Á
  • sudden death
    ±Þ»ç
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
SIDS Sudden Infant Death Syndrome; ¿µ¾Æ µ¹¿¬»ç ÁõÈıº
  = Crib Death
BD barbital-dependent; barbiturate dependence; base deficit; base of prism down; basophilic degeneratio...
ND Doctor of Naturopathy; nasal deformity; natural death; Naval Dispensary; neonatal death; neoplastic ...
SID single intradermal [test]; Society for Investigative Dermatology; sucrase-isomaltase deficiency; sud...
CAS calcarine sulcus; calcific aortic stenosis; Cancer Attitude Survey; carbohydrate-active steroid; car...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CES-D Center for Epidemiologic Studies - Depression
CES-D Center for Epidemiologic Studies - Depression Scale
CES-D Center for Epidemiological Studies Depression
CESD Centers for Epidemiological Studies Depression Scale
EPS Electrophysiologic Studies
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • JrId: 4071
    JournalTitle: Death studies.
    MedAbbr: Death Stud
    ISSN: 0748-1187
    ESSN:
    IsoAbbr:
    NlmId: 8506890
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • accelerated death phase
    °¡¼Ó »ç¸ê±â
  • adjusted death rate
    Á¶Á¤ »ç¸Á·ü
  • black death
    Èæ»çº´
  • bone marrow death
    °ñ¼ö »ç
  • brain death syndrome
    ³ú»ç ÁõÈıº
  • cell death
    ¼¼Æ÷»ç
    ¼¼Æ÷°¡ Á׾´Â °úÁ¤¿¡¼­ »ýü ÀÛ¿ëÀÌ ¼¼Æ÷ ¼öÁØ¿¡¼­ Áß´ÜµÈ ÁöÁ¡. ¼¼Æ÷»ç´Â Á¶Á÷À̳ª Àå±â¸¦ Àå±â ÀÌ½Ä °ø¿©Ã¼·Î »ç¿ëÇÏ´Â °Í¿¡ ¾Õ¼­ ÀϾ´Ù.
  • death certificate
    »ç¸ÁÁø´Ü¼­, ½Ãü°Ë¾È¼­
  • death ratio
    »ç¸Áºñ
    µ¿ÀǾî=
  • death wound
    Ä¡¸í»ó
    Á×À½ÀÇ ¿øÀÎÀÌ µÈ »óó.
  • electric death
    °¨Àü»ç
  • hebdomadal death rate
    »ýÈÄ ÀÏ ÁÖ°£ »ç¸Á·ü
  • immediate death
    Áï»ç, ¼ø°£»ç
  • manner of death
    »ç¸ÁÀÇ Á¾·ù
  • maternal death rate
    ¸ð¼º »ç¸Á·ü
  • molecular death
    ºÐÀÚ »ç
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
retrospective studies Studies used to test aetiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.
(12 Dec 1998)
pharmalogical studies <pharmacology> Studies to assess the potential harmful or other effects of drugs
(16 Dec 1997)
clinical studies <pharmacology> Human studies that are designed to measure the safety, efficacy, and appropriate dosage of a new drug or biological. Clinical studies routinely involve the use of a placebo group that is given an inactive substance that looks like the test product.
(14 Nov 1997)
cohort studies Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesised to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.
(12 Dec 1998)
combination studies <pharmacology> Studies in which a new drug is evaluated in combination with existing drugs.
(09 Jan 1998)
multicenter studies Controlled studies which are planned and carried out by several cooperating institutions to assess certain variables and outcomes in specific patient populations, for example, a multicenter study of congenital anomalies in children.
(12 Dec 1998)
multivariate studies The use of statistical techniques for the simultaneous investigations of the influence of several variables.
(05 Mar 2000)
preclinical studies <pharmacology> Studies in which a drug is tested on animals and in other non-human test systems. Safety information from such studies are used to support an investigational new drug application.
(14 Nov 1997)
sampling studies Studies in which a number of subjects are selected from all subjects in a defined population. Conclusions based on sample results may be attributed only to the population sampled.
(12 Dec 1998)
prospective studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.
(12 Dec 1998)
his bundle studies <cardiology> This test studies the electrical activity of the bundle of HIS.
The bundle of HIS is a group of electrical fibres in the heart that are responsible for transmitting the electrical impulses which generate a normal cardiac contraction. This test may be performed in cases of cardiac arrhythmias, to locate a specific area responsible for a conduction defect and to determine the need for cardiac pacemaker placement.
The test involves the passage of a an electrode tipped catheter into the heart. This catheter is usually threaded through a neck, arm or chest vein. Measurements of the HIS bundle can then be performed while standard ECG leads are placed on the arms and legs.
This test carries a small risk of bleeding, arrhythmias, embolism, heart attack and stroke. It is performed by a specially trained cardiologist.
(27 Sep 1997)
immunofluorescent studies <technique> A special assay that relies on the production of measurable fluorescent light. An immunofluorescent tagged antibody interacts and binds with an antigen allowing an indirect measurement of its concentration.
(27 Sep 1997)
intervention studies Epidemiologic investigations designed to test a hypothesised cause-effect relation by modifying the supposed causal factor(s) in the study population.
(12 Dec 1998)
intracardiac electrophysiology studies <cardiology, investigation> A special study that involves the placement of electrodes inside the heart to map the electrical characteristics of the heart.
This study is carried out in a specially equipped lab and is similar to a cardiac catheterisation procedure. Electrodes are placed inside the heart via a catheter placed into a vein. The electrodes are positioned near the heart's conduction system and an electrical map of the heart can be determined.
This test is often performed in those where a life-threatening cardiac arrhythmia is a problem. The location and characteristics of an arrhythmia can be determined, thus guiding medical management of the problem. Patients with Wolf Parkinson White syndrome or sick sinus syndrome may have this test as part of their evaluation.
(27 Sep 1997)
organizational case studies Descriptions and evaluations of specific health care organizations.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • International Institute for Strategic Studies
    (¿µ)±¹Á¦ Àü·«¿¬±¸¼Ò(I.I.S.S)
  • peace studies
    ÆòÈ­ ¿¬±¸(°­ÁÂ)
  • death
    Á×À½,Àü¸ê,»çÇü
  • Death Valley
    µ¥½º ¹ë¸®;Á×À½ÀÇ °è°î
  • black death
    Èæ»çº´;Æä½ºÆ®
  • cerebral death
    ³ú»ç
  • civil death
    ½Ã¹Î±Ç »ó½Ç;¹ý·ü»óÀÇ »ç¸Á
  • clinical death
    ÀÓ»ó»ç(±â±â¿¡ ÀÇÁ¸ÇÏÁö ¾Ê°í ÀÓ»óÀû °üÂû·Î ÆÇ´ÜÇÑ Á×À½)
  • cot death
    ¿ä¶÷»ç(¾î¸°¾Ö°¡ ÀÚ´Ù°¡ °©ÀÚ±â Á×´Â º´)
  • crib death
    À¯¾ÆÀÇ µ¹¿¬»ç
  • death
    »ç¸Á;Á×À½;¼Ò¸ê;»çÀÎ;»ç½Å;Á×À½ÀÌ °¡±õ´Ù;¿¡ ´ÉÇÏ´Ù;À» ¾ÆÁÖ ÁÁ¾ÆÇÏ´Ù;ÀÇ »çÀÎÀÌ µÇ´Ù;...À» ÁÖ´Ù
  • death Knell
    Á¶Á¾;Á×À½(Á¾¾ð)ÀÇ ÀüÁ¶;Á¾°á(ÆóÁö)À» ÀçÃËÇÏ´Â °Í
  • death adder
    (¿À½ºÆ®·¹Àϸ®¾Æ»ê)µ¶»çÀÇ ÀÏÁ¾
  • death agony
    Á×À½ÀÇ °íÅë
  • death bell
    ÀÓÁ¾À» ¾Ë¸®´Â Á¾
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á